Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy

Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy

Abstract Background Cardiovascular protection following empagliflozin therapy is not entirely attributable to the glucose lowering effect. Increased hematocrit might influence the shear stress that is the main force acting on the endothelium, regulating its anti-atherogenic function. Objective We de...

Full description

Bibliographic Details
Main Authors: Concetta Irace, Francesco Casciaro, Faustina Barbara Scavelli, Rosa Oliverio, Antonio Cutruzzolà, Claudio Cortese, Agostino Gnasso
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Cardiovascular Diabetology
Subjects:
Empagliflozin
Blood viscosity
Rheology
Shear stress
Intima-plus media thickness
Online Access:http://link.springer.com/article/10.1186/s12933-018-0695-y

Internet

http://link.springer.com/article/10.1186/s12933-018-0695-y

Similar Items